Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03093961 · ClinicalTrials.gov registry record · NA
Reduce Lap-hfref Trial
A NA study of Heart Failure, sponsored by Corvia Medical.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 4
- Study locations
NCT03093961 is a NA study of Heart Failure that is active but no longer recruiting, run by Corvia Medical. The registered enrollment target is 10 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT03093961, a NA study of Heart Failure, is active but no longer recruiting, sponsored by Corvia Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of this pilot study is to evaluate the safety and performance of implanting the IASD® System II in Heart Failure patients with reduced ejection fraction and elevated left sided filling pressures, who remain symptomatic despite Guideline Directed Medical Therapy (GDMT).
Conditions Studied
Interventions
- DEVICE IASD implant
Study Locations (4)
Other
- St. Vincent Hospital - Sydney
- Homolka Hospital - Prague
New York
- Mt. Sinai Hospital - New York
New South Wales
- John Hunter Hospital - New Lambton Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-03-10 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03093961
The ClinicalTrials.gov registry entry for NCT03093961 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The listed sponsor is Corvia Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which IASD implant is the first listed.
NCT03093961 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, New South Wales.
Frequently Asked Questions
What is clinical trial NCT03093961 about?
NCT03093961 is a clinical study titled "Reduce Lap-hfref Trial". The objective of this pilot study is to evaluate the safety and performance of implanting the IASD® System II in Heart Failure patients with reduced ejection fraction and elevated left sided filling pressures, who remain symptomatic despite Guideline Directed Medical Therapy (GDMT).
What is the current status of trial NCT03093961?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2017-03-10. Estimated completion is 2027-12.
What conditions does trial NCT03093961 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03093961?
The interventions under investigation include: IASD implant (DEVICE).
Who is sponsoring clinical trial NCT03093961?
This trial is sponsored by Corvia Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03093961 being conducted?
This trial has 4 study locations across New York, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.